Taiwan's Medeologix buys three Silicon Valley medical device CDMO companies
Contract Manufacturing | News | 0 Comment | 29 Nov, 2022
Medeologix, a Taiwan-based medtech CDMO company, has announced its successful acquisition of three premier medical devic...Read more
WuXi opens integrated biologics CRDMO centre in Shanghai
Contract Manufacturing | News | 0 Comment | 22 Nov, 2022
WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organisation (CRDMO), has launched its...Read more
WuXi establishes new vaccines CDMO facility in China
Contract Manufacturing | News | 0 Comment | 15 Nov, 2022
WuXi Vaccines, a leading global Contract Development and Manufacturing Organisation (CDMO), has entered into an agreemen...Read more
I Peace partners with the California Institute for Regenerative Medicine
Contract Manufacturing | News | 0 Comment | 03 Nov, 2022
Founded in 2015 by Koji Tanabe, a graduate of Professor Shinya Yamanaka's laboratory at Kyoto Univer...Read more
Terumo invests ¥15 B to expand CDMO services outside Japan
Contract Manufacturing | News | 0 Comment | 01 Nov, 2022
Terumo Pharmaceutical Solutions (TPS), a leading manufacturer of injection, primary container, and infusion therapy devi...Read more
Lotte Biologics signs MoU with Huons Global for biologics manufacturing
Contract Manufacturing | News | 0 Comment | 01 Nov, 2022
South Korea-based startup Lotte Biologics has signed a memorandum of understanding (MoU) with Huons Global for clinical ...Read more
WuXi Biologics launches new manufacturing facility in China
Contract Manufacturing | News | 0 Comment | 26 Oct, 2022
WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), has successfully...Read more
Samsung Biologics unlocks additional capacity for production at newest Plant 4
Contract Manufacturing | News | 0 Comment | 12 Oct, 2022
Samsung Biologics, South Korea-based contract development and manufacturing organization (CDMO), has announced that its ...Read more
Fujifilm to establish first Bio-CDMO site in Japan
Contract Manufacturing | News | 0 Comment | 10 Oct, 2022
Fujifilm Corporation has announced that it will establish the company’s first Japanese Bio-CDMO (contract developm...Read more
Cytiva strengthens cell line development with CEVEC acquisition
Contract Manufacturing | News | 0 Comment | 06 Oct, 2022
Global life sciences leader Cytiva has acquired CEVEC Pharmaceuticals, a leading German provider of high-performance cel...Read more
Samsung Biologics to launch new platforms for antibody development process
Contract Manufacturing | News | 0 Comment | 30 Sep, 2022
South Korea-based Samsung Biologics, a world-leading contract development and manufacturing organization (CDMO), is laun...Read more
Biosyngen boosts cell therapy GMP capabilities in Singapore
Contract Manufacturing | News | 0 Comment | 28 Sep, 2022
Singapore-based startup Biosyngen has signed to set up a cell therapy GMP facility which will serve as a base to develop...Read more
WuXi STA opens first high potency oral drug product manufacturing facility
Contract Manufacturing | News | 0 Comment | 28 Sep, 2022
WuXi STA, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has announced the ope...Read more
Bora Pharma partners with TaiRx to manufacture breakthrough anticancer drug in Taiwan
Contract Manufacturing | News | 0 Comment | 26 Sep, 2022
Bora Pharmaceutical Laboratories Inc. (Zhunan), a division of Bora Pharmaceuticals has partnered with TaiRx, Inc., a Tai...Read more
Hong Kong-based startup Great Bay Bio secures $15M funding
Contract Manufacturing | News | 0 Comment | 15 Sep, 2022
Great Bay Bio (GBB), Hong Kong-based startup, has announced the completion of its $15 million Pre-series B funding ...Read more
Catalent invests $2.2M for Singapore clinical supply facility expansion
Contract Manufacturing | News | 0 Comment | 07 Sep, 2022
Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, lau...Read more
Dr Glenn Haifer and Ampersand Capital Partners acquire Australian biologics CDMO Luina Bio
Contract Manufacturing | News | 0 Comment | 01 Sep, 2022
AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, has been acquired by biotech investor Dr Gle...Read more
WuXi Biologics opens first North American biomanufacturing facility in New Jersey
Contract Manufacturing | News | 0 Comment | 01 Sep, 2022
China's WuXi Biologics, a global leading Contract Research, Development and Manufacturing Organization (CRDMO), has anno...Read more